Patents by Inventor Preston E. Bratcher

Preston E. Bratcher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11986450
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Grant
    Filed: May 3, 2022
    Date of Patent: May 21, 2024
    Assignee: National Jewish Health
    Inventors: Brian J. Day, Preston E. Bratcher
  • Patent number: 11963965
    Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
    Type: Grant
    Filed: December 22, 2020
    Date of Patent: April 23, 2024
    Assignee: National Jewish Health
    Inventors: Preston E. Bratcher, Pamela L. Zeitlin
  • Publication number: 20220280467
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Application
    Filed: May 3, 2022
    Publication date: September 8, 2022
    Inventors: Brian J. Day, Preston E. Bratcher
  • Patent number: 11351141
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: June 7, 2022
    Assignee: National Jewish Health
    Inventors: Brian J. Day, Preston E. Bratcher
  • Publication number: 20210196728
    Abstract: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
    Type: Application
    Filed: December 22, 2020
    Publication date: July 1, 2021
    Inventors: Preston E. Bratcher, Pamela L. Zeitlin
  • Publication number: 20210030706
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Application
    Filed: July 20, 2020
    Publication date: February 4, 2021
    Inventors: Brian J. Day, Preston E. Bratcher
  • Patent number: 10751315
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: August 25, 2020
    Assignee: National Jewish Health
    Inventors: Brian J. Day, Preston E. Bratcher
  • Publication number: 20190083440
    Abstract: The present invention generally relates to methods and compositions for treating pulmonary infections and inflammation with a composition comprising selenocyanate, hyposelenocyanite or a selenocyanate conjugate.
    Type: Application
    Filed: August 29, 2018
    Publication date: March 21, 2019
    Inventors: Brian J. Day, Preston E. Bratcher